Connect with us

Cannabis News

Only Six Percent Of Marijuana Consumers Approve Of Trump’s Reform Actions, But Most Would Shift Opinion If He Reschedules, Poll Finds

Published

5 months ago

on

Only six percent of marijuana users approve of the Trump administration’s actions on cannabis policy so far, according to a new poll. Rumors abound that the president plans to direct federal rescheduling of cannabis.

The latest version of NuggMD and Marijuana Moment’s quarterly presidential approval tracking poll also found that 51 percent of respondents would support the current administration if marijuana were rescheduled or legalized.

Some President Donald Trump calls cannabis III. Despite the recent news that plans to reclassify the drug as Schedule I under the Controlled Substances Act are very positive, marijuana users’ support for the president’s marijuana “actions” declined in the last quarter.

1.6 percent of respondents said they “strongly approve” of the actions, 4.5 percent approve, a plurality of 38.4 percent are neutral, 26.1 percent disapprove and 29.5 percent strongly disapprove.

“Do you approve or disapprove of the presidential administration’s actions regarding cannabis?”
n: %
Strongly accept 7 1.6%
accept 20 4.5%
No opinion/Neutral 172 38.4%
Condemn 117 26.1%
Very disapproving 132 29.5%
448
Score (-50 to +50) -19,364
Clear Accept/Reject: -49.6%

However, the poll data also reinforced the idea that Trump could move the needle among cannabis-using voters by enacting key reforms, such as rescheduling or legalization.

It found that among respondents, 51 percent said they would change their level of support for the president if he took action on these reform proposals.

1.5 percent said they would support it less, while 47.5 percent said their opinion would not change.

“If the Trump administration were to reschedule or legalize cannabis, would that change your level of support?”
n: %
I would accept much more 172 38.4%
I could tolerate a bit more 56 12.5%
No change 213 47.5%
I would accept less 2 0.4%
I would accept much less 5 1.1%
448
Score (-50 to +50): 21,652
Clear Accept/Reject: 49.3%

“I find these data to be evidence that the White House needs to take tangible action on cannabis reprogramming to capture the clear political benefit of the public we poll, cannabis consumers who participate in state legal and regulated markets,” said Andrew Graham, chief communications officer for Nugg MD, Marijuana Moment.

“The trial balloon about the imminence of the overhaul is not going to cut it,” he said, adding that he doesn’t believe an executive leading the move to Schedule III “resolves the many problems with how federal law treats cannabis, a legal substance in many states.”

However, “I think it would benefit the industry and increase access, and consumers of cannabis would notice,” Graham said.

The latest quarterly poll found Trump’s overall approval rating among marijuana users down, from 11 percent in the previous quarter to around six percent this quarter.

The survey — which interviewed 448 cannabis users living in states with legal markets and has a margin of error of ±4.63 percentage points — was conducted before the president announced plans to move forward with the reorganization process initiated by the Biden administration, with deadlines for action ranging from Monday to early next year.

Trump confirmed Monday when asked by a reporter “very strongly” considering rescheduling cannabisHe said the reform “brings in enormous amounts of research that can’t be done if you don’t reclassify.”

Amid rumors of a reconsideration, top Democrats in Congress have complained that the reform would not go far enough, including Sen. Ron Wyden (D-OR) who called the move only a tentative one. president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval rating.

Meanwhile, it is an important organization in the drug testing industry Amid ‘sounding the alarm’ reports Trump may soon end marijuana reregulation proposalthat the reform would have “catastrophic consequences for the safety of US workers and the transportation sector.”

Cannabis industry players are hopeful that reform will be passed as soon as possible, but opponents — including the National Drug and Alcohol Screening Association (NDASA) and Smart Approaches to Marijuana (SAM) — are working to dissuade the administration before a final decision is made. For what it’s worth, a White House spokesperson told Marihuana Moment that no action has been taken so far.

They have been bipartisan members of Congress weighing a possible decision to reorganize last week—Democrats like Rep. Alex Ocasio-Cortez (D-NY) call the reform a “no” and others like Rep. Andy Harris (R-MD) have pushed back against the proposal.

Trump said this in mid-August he would make the reorganization decision in a week. But despite that timeline and increasing rumors, a White House spokesman told Marijuana Moment last week that “no final decision has been made on rescheduling marijuana.”

The Washington Post reported Thursday afternoon that Trump planned to issue an executive order to federal agencies to move ahead with cannabis rescheduling.

The outlet also said the president met with marijuana industry executives Robert F. Kennedy Jr. earlier this week in the Oval Office. with Secretary of Health and Human Services and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump called Johnson, the House Speaker, who opposed the rescheduling of cannabis,

If the administration ultimately enacts the rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition half a century ago, when it was banned under Article III. With a reclassification, marijuana has medical value and a lower abuse potential compared to Schedule I drugs like heroin.

—
It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Trump endorsed the rescheduling — as well as an initiative to legalize access to industrial banking and adult use in Florida — on the campaign trail. The president had been silent on the issue since taking office for a second term, until a meeting in August where, in response to a reporter’s question, he announced that the administration would decide to reschedule in a few weeks.

The possibility of an immediate rescheduling announcement comes a few weeks later the president signed a major spending bill that would effectively ban most consumer hemp productsdrawing criticism from hemp industry players who say the policy change would wipe out the market.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Related Topics:
Continue Reading

Cannabis News

Texas Judge Allows Smokable Hemp And Other Products To Be Sold, Blocking State Ban From Being Enforced

Published

10 hours ago

on

May 2, 2026

By

A Texas judge has issued a temporary injunction that continues to prevent state officials from enforcing the news Regulations restricting access to hemp-derived products such as THCA combustible flower. Meanwhile, the state Supreme Court in a separate case allows regulators to ban delta-8 THC.

Friday’s ruling by Judge Daniella DeSeta Lyttle follows another judge last month who issued a temporary restraining order on the ban on hemp products. According to the latest order, sales of hemp products can continue until at least July 27.

Decisions a a lawsuit filed by a coalition of hemp industry leaders and advocacy organizations The Department of State Health Services (DSHS) and the Health and Human Services Commission (HHSC) have accused lawmakers of effectively circumventing the law. ban the sale and manufacture of certain hemp consumable products.

Under state law passed by the legislature and governor in 2019, the suit says cannabis products are legal if they contain no more than 0.3 percent delta-9 THC. But regulators at DSHS and HHSC recently approved a “total delta-9 THC” limit using a post-decarboxylation formula that includes tetrahydrocannabinolic acid (THCA) in the calculation.

Texas lawmakers passed legislation to severely restrict hemp products in the 2025 session, but Gov. Greg Abbott (R) vetoed it and did not make it into law.

Lyttle said Friday that the plaintiffs have established “a possible right to relief on the merits of their claims.”

“In the absence of injunction, plaintiffs will suffer immediate and continuing harm to their business operations, legal rights and economic interests,” he said. he wrote. “These damages include disruption of established supply chains, loss of market access, impairment of goodwill and customer relationships, and the risk of significant compliance costs and enforcement consequences under the rules that plaintiffs have proven invalid.”

The hemp industry lawsuit, which also lists Attorney General Ken Paxton (R) as a defendant, also calls into question large increases in business license fees that were approved by regulators. Under the new rules, the cost of a manufacturer’s license increased from $250 to $10,000 per facility, while the retailer registration fee increased from $150 to $5,000 per location.

While the judge who issued a temporary restraining order on the product restrictions last month did not grant a stay on the new fees, Lyttle included them within the scope of his temporary injunction.

“These measures do not impose policy choices of the Legislature; they supersede them,” says the initial complaint filed by plaintiffs Texas Hemp Business Council (THBC) and Hemp Industry & Farmers of America (HIFA). “And they do so against the backdrop of a constitutional legislative process that ran its entire course — from the legislative passage of Senate Bill 3 to the governor’s veto, two failed special sessions — and produced an ambiguous result: no new law. Texas law does not allow agencies to override that result through rulemaking.”

“Texas has long promoted itself as a national leader in economic growth and regulatory stability. It is a state committed to fostering innovation, supporting legitimate businesses, and maintaining a predictable legal environment in which businesses can operate and invest,” he says. “Consistent with that vision, Texas has chosen to authorize and regulate the manufacture, distribution and sale of consumable hemp products (‘CHP’) through a comprehensive statutory framework enacted by the Legislature in 2019.”

“Plaintiffs acknowledge this framework and the State’s interest in ensuring that CHPs are produced and sold in a safe, responsible and lawful manner,” the lawsuit states.

In a state Supreme Court ruling Friday, the justices overturned a lower court’s order that prevented regulators from treating delta-8 THC as a controlled substance.

“The companies that developed these products claim that the legislature opened up the market to them in 2019,” the court’s opinion says. “So when the commissioner sought to clarify that, in fact, the legislature had not clarified the potent levels of delta-8 THC manufactured in consumable hemp products, a group of businesses and consumers asked a court to rewrite the controlled substance schedules for him and the department, especially since the legislature legalized delta-8 THC in 2019 making the commissioner’s actions impossible and ultra vires.”

“The trial court granted that relief by way of a temporary injunction, which was affirmed by the appeals court. We now conclude that the lower courts exceeded their jurisdiction,” the justices said. find. “If the legislature wants to legalize powerful drugs, it has all the tools it needs to do so, and that is inevitable, as we expect such a big change in social policy. The role of the courts is simply to evaluate the state of the law as it stands.”

Separately, Texas officials conditionally approved more new medical marijuana business licenses As part of a law being implemented to significantly expand the state’s cannabis program.

A recent survey showed that Texas voters overwhelmingly support legalizing medical marijuana they still do not know, to a large extent, about the existing program.

in march Texas voters approved a question to legalize marijuana that showed up in the state’s Democratic primary voting.

Another statewide survey released in February found that Texas voters don’t like how state leaders and lawmakers have handled marijuana and THC policy issues. In the poll, many voters (40 percent) said they disapprove of how their elected officials have approached the issue, according to the poll. 29 percent said they approve of how cannabis issues have been handled, while 31 percent said they had no opinion either way.

A separate survey released last year proved this Many Texas voters want the state’s marijuana laws to be “less strict.” And among the issues examined by members of parliament in the last special sessions, the voters said that a proposal to deal with the regulation of hemp was one of the least important.

Meanwhile, the lieutenant governor and speaker of the House recently announced that the state will continue with their own ibogaine research program The drug companies did not submit proposals to meet the requirements and standards for receiving state funds under a recently passed law to begin clinical trials with the psychedelic.

Image courtesy of AnonMoos.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Cannabis growth facility eyes new spot for growth facility near Crisfield

Published

1 day ago

on

May 1, 2026

By











The Somerset County Board of Zoning Appeals approved another special exception for a cannabis-growing facility after negotiations to purchase a previous location failed to reach an agreement.

Trilogy Group LLC was granted a license to grow by the Maryland Cannabis Association, with the condition that the business be operational by July 2026. Trilogy Group wants to operate on the county-owned, undeveloped industrial site on Revell’s Neck Road in Westover. However, this project time frame does not coincide with the license term.

In September 2025, the producer was approved for a special exception for a facility at 4630 Crisfield Highway. The existing building houses Jed’s Auto Refinishing, which would be renovated to accommodate the growing operations. When the sale of that property ultimately failed, Trilogy Group purchased the land at 4381 Crisfield Highway and obtained another special exemption.

Jesse Drewer, Somerset’s Director of Technical and Community Services, said: “They looked for a site they already owned before coming to us and working through the process. “They are landlords and developers all in one.”

Read more at WBOC










Continue Reading

Cannabis News

Trump’s New Surgeon General Pick Said Using Marijuana Can Give You ‘Man Boobs’

Published

1 day ago

on

May 1, 2026

By

President Donald Trump’s new surgeon general nominee has raised concerns about marijuana, at one point saying its use is linked to the development of large breasts, or “man boobs,” in men. However, he also admitted that medical cannabis has “potential benefits”.

Trump announced Thursday that he would tap Nicole Saphier, who is now the director of breast imaging at Memorial Sloan Kettering, to be the surgeon general of the United States.

Saphier has repeatedly discussed what he sees as the dangers of marijuana use, and has been more open to the potential benefits of its non-intoxicating ingredient CBD.

“There is a common misconception that marijuana is safer than alcohol and other drugs,” he wrote on Fox News in 2019. “As a doctor I know that marijuana is not harmless and can have serious adverse effects on the health of users.”

“And as a mother of three (one in college), I’m concerned that legalizing the drug for adults sends a clear message to kids that they can get pot without negative health effects,” she said.

Saphier went on to criticize the 2020 Democratic presidential candidates who supported marijuana reform, saying it’s “politically a popular cause, especially among young voters.”

“These candidates are more interested in how legalization of pot will affect their electoral prospects than how legalization will affect public health,” he said. he wrote.

Among the health concerns he has raised is that cannabis use is “directly linked” to “man boobs”.

“Physically, we know that marijuana is directly linked to respiratory problems (if smoked), cardiovascular disease, and gynecomastia (“man nipples”). As a breast radiologist, the first question I ask men when they come in for breast augmentation is whether they currently smoke marijuana or have smoked it in the past. Often, the answer is “yes.”

Trump’s appointment of Saphier comes just as his administration is moving forward with federal rescheduling of marijuana.

Although the surgeon general has no formal involvement in the drug program, which is administered by the Department of Justice and the Department of Health and Human Services, the position is seen as “America’s doctor” and plays a role in addressing health issues on behalf of the government.

In a podcast earlier this year, Saphier admitted that there are “potential benefits” to medical cannabis.

“Of course, there is evidence supporting cannabinoids for chemotherapy-induced nausea, certain seizure disorders, chronic pain syndromes, multiple sclerosis,” he said. “But that’s very different than, you know, the general normalization of high-potency recreational cannabis on a daily basis, especially in developing brains, which doesn’t happen until age 25.”

In the same podcast, he said that he personally “doesn’t like” and has “never tried” cannabis.

“I think CBD products are probably significantly less harmful if they don’t have THC. I’m not a fan of THC,” Saphier. he said. “I think if people are trying to get away from alcohol and want to take low doses of CBD, not inhale it, not smoke it, I’m sure it’s probably less risky than some of the other things out there.”

“Let’s be honest, today’s cannabis is not your parents’ marijuana. The potency of THC has increased dramatically over the last two decades. High-concentrate products, vapes, dabs, edibles, what the kids are doing these days, I don’t even know.”

In another interview focused on concerns about cannabis use by pregnant women, Saphier he said “As we continue to legalize marijuana, people are equating that to, ‘it has to be safe.'”

In a separate interview, he suggested that the legalization of cannabis is increasing its use among young people, which he said increases rates of addiction and psychosis.

“One in six children who try it, becomes addicted. Cannabis use in children, the risk of psychosis is four times higher,” he said. “What have we done? Legalize. Normalize.”

Trump’s predecessor, now retired Candidate Casey Means discussed his “significant experiences” with psychedelics beforehand Saying that marijuana “can greatly decrease your ability to generate good energy.”

Means himself said during a confirmation hearing in February he would not advise Americans to experiment with psychedelics as he has donebut noted that there is “exciting” research indicating that substances such as psilocybin can effectively treat serious mental health conditions.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media